Overview

Metformin and Sitagliptin in Women With Previous Gestational Diabetes

Status:
Completed
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The goal of the present research is to compare the effects of treatment with metformin and sitagliptin, alone or in association, in women with previous gestational diabetes to evaluate the impact of the two drugs on beta-cell function. The study results may contribute to give a rational approach for future investigations.
Phase:
Phase 2
Details
Lead Sponsor:
University of Pisa
Collaborator:
Merck Sharp & Dohme Corp.
Treatments:
Metformin
Sitagliptin Phosphate